Table 1.

Biomarker Distribution in the Final Patient Cohort (58 Patients)

Biomarker		Number	Percent
PI3K hotspot mutations	Wild	17	70.2%
Mutant	7	29.2%
Missing	34
Nuclear LKB1	Low	11	34.4%
High	21	65.6%
Missing	26
Cytoplasmic LKB1	Low	12	37.5%
High	20	62.5%
Missing	26
Nuclear pAKT	Low	12	37.5%
High	20	62.5%
Missing	26
Cytoplasmic pAKT	Low	10	31.2%
High	22	68.8%
Missing	26
P4EBP1	Low	19	57.6%
High	14	42.4%
Missing	25
pS6RP	Low	14	42.2%
High	19	57.6%
Missing	25